CRIS Current Research Information System

BONIFAZI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.279
NA - Nord America 4.051
EU - Europa 3.667
AF - Africa 320
SA - Sud America 217
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.549
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.007
CN - Cina 1.321
SG - Singapore 1.292
IT - Italia 1.064
VN - Vietnam 727
GB - Regno Unito 522
SE - Svezia 450
DE - Germania 433
HK - Hong Kong 308
NL - Olanda 238
KR - Corea 204
IN - India 201
RU - Federazione Russa 153
BR - Brasile 144
FI - Finlandia 127
IE - Irlanda 124
UA - Ucraina 119
FR - Francia 113
CI - Costa d'Avorio 110
TG - Togo 79
AT - Austria 70
JP - Giappone 63
JO - Giordania 54
BG - Bulgaria 52
SC - Seychelles 52
CH - Svizzera 47
ZA - Sudafrica 40
AR - Argentina 36
BE - Belgio 32
CA - Canada 30
EE - Estonia 24
ID - Indonesia 24
NG - Nigeria 24
ES - Italia 18
EC - Ecuador 17
PL - Polonia 16
AU - Australia 13
CL - Cile 13
IR - Iran 12
LT - Lituania 12
MX - Messico 11
TR - Turchia 11
BD - Bangladesh 10
HR - Croazia 8
CZ - Repubblica Ceca 6
DK - Danimarca 6
RO - Romania 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
PT - Portogallo 5
TW - Taiwan 5
IQ - Iraq 4
LB - Libano 4
NO - Norvegia 4
PK - Pakistan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
EG - Egitto 3
KE - Kenya 3
KG - Kirghizistan 3
PH - Filippine 3
PY - Paraguay 3
CO - Colombia 2
GE - Georgia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TJ - Tagikistan 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LI - Liechtenstein 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
MW - Malawi 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 12.549
Salva come PNG Salva come JPEG
Città #
Singapore 896
Ashburn 514
Chandler 456
Hefei 442
Southend 416
Hong Kong 305
Bologna 303
Fairfield 300
Seoul 201
Ann Arbor 184
Dong Ket 172
Beijing 162
Ho Chi Minh City 161
Hanoi 144
Woodbridge 144
Seattle 138
Wilmington 138
Houston 128
Dublin 123
Santa Clara 120
Princeton 119
Abidjan 109
Boardman 103
Dallas 99
New York 91
Helsinki 87
Cambridge 83
Los Angeles 82
Jacksonville 79
Lomé 79
Milan 75
Munich 61
Tokyo 59
Amman 54
Sofia 51
Vienna 47
Bremen 46
Berlin 45
Nanjing 45
Bern 42
Westminster 40
Bengaluru 39
Frankfurt am Main 38
Turin 37
Buffalo 35
Redondo Beach 34
Florence 32
Brussels 31
Padova 31
Rome 31
Hyderabad 24
Redmond 24
Saint Petersburg 24
San Diego 24
Turku 23
Guangzhou 22
Abeokuta 21
Nuremberg 21
London 20
Amsterdam 19
Jakarta 18
Phoenix 18
Shanghai 18
Brooklyn 17
Jinan 17
São Paulo 17
Hebei 16
Toronto 16
Biên Hòa 15
Reggio Emilia 15
Verona 15
Castel Maggiore 14
Changsha 14
Da Nang 14
Lappeenranta 14
Mülheim 14
Yubileyny 14
Zhengzhou 14
Chicago 13
Falkenstein 12
Haiphong 12
Medford 12
Nanchang 12
San Francisco 12
Chengdu 11
Modena 11
Norwalk 11
Orem 11
Quận Bình Thạnh 11
The Dalles 11
Tongling 11
Forlì 10
Redwood City 10
Stockholm 10
Warsaw 10
Wuhan 10
Düsseldorf 9
Hải Dương 9
Mumbai 9
Paris 9
Totale 7.989
Salva come PNG Salva come JPEG
Nome #
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. 311
Digitisation of temporary exhibitions: the Aldrovandi case 299
Longitudinal tear protein changes correlate with ocular chronic gvhd development in allogeneic hematopoietic stem cell transplant patients 279
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 268
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation 247
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma. 241
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia 235
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 233
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia 221
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients 216
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. 201
Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission. 200
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. 199
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 197
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. 196
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. 196
Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. 194
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients 192
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia. 191
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 189
Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation 188
Peripheral blood cellular profile at pre-lymphodepletion is associated with {CD}19-targeted {CAR}-T cell-associated neurotoxicity 184
Detection of Brain-Derived Cell-Free DNA in Plasma 181
Developing a new grading system of ocular surface disease after allogeneic hematopoietic stem cell transplantation (HSCT). 172
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 171
Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment. 169
GVHD and prognostic factors. 166
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 162
Eyelid metrics assessment in patients with chronic ocular graft versus-host disease 162
Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells 160
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 157
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. 156
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study. 156
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 156
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis 155
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity 151
Intracranial pressure management in fulminant cerebral oedema after CAR T-cell therapy: Not all is lost! 150
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature 148
Effect on survival of the development of late-onset non-infectious pulmonarycomplications after stem cell transplantation. 147
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 145
Stem cell mobilization and collection in patients with liver cirrhosis. 144
Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patients. 144
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 143
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies. 143
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia 141
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B 138
Dry Eye Disease Is Already Present in Hematological Patients before Hematopoietic Stem Cell Transplantation 136
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 124
Correction to: Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy 116
Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients 116
CMV-RNAemia as new marker of active viral replication in transplant recipients 116
Meibomian Gland Dropout in Hematological Patients Prior to Hematopoietic Stem Cell Transplantation 114
Conjunctival epithelial cells (CEC) morphology in hematological patients before and after hematopoietic stem cell transplantation (HSCT). A Cytological and Confocal Microscopy Study 113
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas 111
Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies 110
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study 110
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 105
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study 104
Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukaemia 103
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 102
PREDICTIVITY OF TEAR PARAMETERS IN THE ONSET OF OCULAR GRAFT VERSUS HOST DISEASE (GVHD) DRY EYE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT). 101
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome 99
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 98
Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8] 98
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 96
Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy 94
Prospective Validation of CAR-HEMATOTOX and a Simplified Version Predict Survival in Patients with Large B-Cell Lymphoma Treated with Anti-CD19 CAR T-Cells: Data from CART-SIE Study 93
Brexucabtagene autoleucel in‐vivo expansion and BTKi refractoriness have a negative influence on progression‐free survival in mantle cell lymphoma: Results from CART‐SIE study 92
Epigenetic age acceleration in hematopoietic stem cell transplantation 91
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation 90
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma 89
null 86
Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation 86
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement 86
Longitudinal Changes of Ocular Surface Microbiome in Patients Undergoing Hemopoietic Stem Cell Transplant (HSCT) 85
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas 83
null 83
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience. 82
Ribosomal DNA instability: An evolutionary conserved fuel for inflammaging 81
Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient 79
Transient Elastography Anticipates the Diagnosis of VOD/SOS after Adult Allogeneic Stem Cell Transplant: Results from a Prospective Study 76
null 75
The role of extracellular DNA in COVID-19: Clues from inflamm-aging 70
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study 67
Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection 67
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 66
SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapy 64
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study 61
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T‐cell pathway in patients with diffuse large B‐cell lymphoma 59
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). 54
Hepatosplenic T-cell non-Hodgkin lymphoma cured with tandem autologous and allogeneic stem cell transplantation 54
Correction to: Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review (Journal of Neurology, (2022), 269, 8, (4560-4563), 10.1007/s00415-022-11117-8) 47
Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma 39
Hematopoietic stem cell transplantation disrupts age-related gut microbiota signatures in pediatric and adult recipients 23
Factors influencing the perception of protective isolation in patients undergoing haematopoietic stem cell transplantation: A multicentre prospective study 21
Development and initial validation of a questionnaire to assess patients’ perception of protective isolation following haematopoietic stem cell transplantation 15
Totale 12.824
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.167
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021544 0 0 0 0 0 45 7 52 60 48 57 275
2021/20221.418 78 36 73 152 96 46 49 119 84 143 331 211
2022/20231.931 216 282 106 250 125 151 56 103 301 41 194 106
2023/2024758 56 85 63 105 64 175 25 44 15 38 58 30
2024/20253.042 128 331 233 207 242 157 210 160 80 309 243 742
2025/20263.387 586 814 581 566 579 261 0 0 0 0 0 0
Totale 12.824